Osteoporosis and Parkinson's disease

Clinical Cases in Mineral and Bone Metabolism

Volumn 8, Issue 3, 2011, Pages 16-18

  Raglione, Laura Maria ^a   Sorbi, Sandro ^a   Nacmias, Benedetta ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Fall, vitamin D; Fracture; Osteoporosis; Parkinson's disease

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL; RISEDRONIC ACID;

BONE DENSITY; FALLING; FRACTURE; HIP FRACTURE; HUMAN; IATROGENIC DISEASE; IMMOBILIZATION; MORBIDITY; MORTALITY; NUTRITION; OSTEOPOROSIS; PARKINSON DISEASE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; RISK REDUCTION; SHORT SURVEY; VITAMIN D DEFICIENCY;

EID: 84856098148     PISSN: 17248914     EISSN: 19713266     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (37)

1. Invernizzi M, Carda S, Sguazzini Viscontini G et al. Osteoporosis in Parkinson's disease. Parkinsonism and Related Disorders 2009;15:339-346.
2. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-9. (Pubitemid 29046907)
3. Consensus Development Conference. JAMA 2001;285:785-795.
4. Bezza A, Ouzzif Z, Naji H et al, Prevalence and risk factors of osteoporosis in patients with Parkinson's disease. Rheumatol Int 2008;28:1205-1209.
5. Dargent-Molina P, Favier F, Grandjean H et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet 1996;348(9021):145-9. (Pubitemid 26238096)
6. Taylor BC, Schreiner PJ, Stone KL et al. Long-term prediction of incident hip fracture risk in elderly white women:study of osteoporotic fractures. J Am Geriatr Soc 2004;52:1479-86. (Pubitemid 39209595)
7. Koller W, Glatt S, Vetere-Overfield B et al. Falls and Parkinson's disease. Clin Neuropharmacol 1989;2:98-105. (Pubitemid 19088635)
8. Wielinski Cl, Erickson-Davis C, Wichmann R et al. Falls and injuries resulting from falls among patients with Parkinson's disease and other Parkinsonian syndromes. Mov Disord 2005;20:410-5. (Pubitemid 40779015)
9. Stalenhoef PA, Diederiks JP, Knottnerus JA et al, A risk model for the prediction of recurrent falls in community-dwelling elderly: a prospective cohort study. J Clin Epidemiol 2002;55:1088-94. (Pubitemid 36050081)
10. Woodford H, Walker R. Emergency hospital admissions in idiopathic Parkinson's disease. Mov Disord 2005;20:1104-8. (Pubitemid 41632195)
11. Yamada T, Kachi T, Ando K. Osteoporosis and fractures in Parkinson's disease. Nippon Ronen Igakkai Zasshi 1995;32:637-40. (Pubitemid 26012547)
12. Taggart H, Crawford V. Reduced bone density of the hip in elderly patients with Parkinson's disease. Age Ageing 1995;24:326-8.
13. Kao CH, Chen CC, Wang SJ et al. Bone mineral density in patients with parkinson's disease measured by dual photon absorptiometry. Nucl Med Com 1994;15:173-7. (Pubitemid 24104354)
14. Ishizaki F, Harada T, Katayama S et al. Bone changes in Parkinson's disease. No To Shinkei 1993;45:719-24. (Pubitemid 23283287)
15. Sato Y, Kaji M, Tsuru T et al. Risk factors for hip fracture among elderly patients with Parkinson's Disease. J Neurol Sci 2001;182:89-93. (Pubitemid 33786703)
16. Sato Y, Kikuyama M, Oizumi K, High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology 1997;49:1273-8. (Pubitemid 27495628)
17. Wood B, Walker R, Osteoporosis in Parkinson's disease. Movement disorder society 2005;20:1636-40.
18. Fink HA, Kuskowski MA, Taylor BC et al. Osteoporotic fractures in men (MrOS) study group. Association of Parkinson's disease with accelerated bone loss, fractures and mortality in older men: the osteoporotic fractures in men (MrOS) study. Osteoporos Int 2008;19:1277-82.
19. Di Monaco M, Vallero F, Di Monaco R et al. Type of hip fracture in patients with Parkinson disease is associated with femoral bone mineral density. Arch Phys Med Rehabil 2008 Dec; 89(12):2297-301.
20. Sato Y, Kaji M, Tsuru T et al. Vitamin K deficiency and osteopenia in vitamin D-deficient elderly women with Parkinson's disease. Arch Phys Med Rehabil 2002;83(1):86-91. (Pubitemid 34052145)
21. Petroni ML, Albani G, Bicchiega V et al. Body composition in advanced- stage Parkinson's disease. Acta Diabetol 2003;40(S):187-190.
22. Johnell O, Melton LJ, Atkinson EJIII et al. Fracture risk in patients with Parkinsonism: A population based study in Olmsted County, Minnesota. Age Ageing 1992;21:32-8.
23. William P, Jr Cheshire, Zbigniew K et al. Body mass index is reduced early in Parkinson's disease. Parkinsonism and Related Disorders 2005;11:35-38.
24. Sato Y, Honda Y, Iwamoto J et al. Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients. Mov Disord 2005;20:1598-603.
25. Triggiani L, Fisiologia e patologia del sistema nervosa centrale. Quale ruolo per la vitamina D. La Neurologia Italiana anno IV - n.4 -2010.
26. Evatt ML, Delong MR, Khazai N et al. Prevalence of vitamin D insufficiency in patients with Parkinson's disease and Alzheimer disease. Arch Neurol 2008;65:1348-52.
27. Newmark HL, Newmark J. Vitamin D and Parkinson's disease: a hypothesis. Mov Disord 2007;22:461-8.
28. Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with Parkinsonism and anti-Parkinson drugs. Calcif Tissue Int 2007;81:153-61. (Pubitemid 47373359)
29. Rogers JD, Sanchez-Saffon A, Frol AB et al. Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease. Arch Neurol 2003;60:59-64. (Pubitemid 36078109)
30. Kanis JA, Burlet N, Cooper C et al. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 2008;19:399-428.
31. Kannus P, Sievanen H, Palvanen M et al. Prevention of falls and consequent injuries in elderly people. Lancet 2005;366:1885-93. (Pubitemid 41690118)
32. Oliver D, Connelly JB, Victor CR et al. Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses. BMJ 2007;334:82.
33. Goodwin VA, Richards SH, Taylor RS et al. The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis. Mov Disord 2008 Apr 15;23(5):631-40.
34. Sato Y, Manabe S, Kuno H et al. Amelioration of osteopenia and hypovitaminosis D by 1alpha-hydroxyvitamin D3 in elderly patients with Parkinson's disease. J Neurol Neurosurg Psychiatr 1999;66:64-8. (Pubitemid 29101490)
35. Sato Y, Honda Y, Iwamoto J. Risedronate and ergocalciferol prevent hip fracture in elderly men with Parkinson disease. Neurology 2007;68:911-5. (Pubitemid 46568502)
36. Sato Y, Iwamoto J, Kanoko T et al. Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial. Mov Disord 2006;21:924-9. (Pubitemid 44184591)
37. Iwamoto J, Matsumoto H, Takeda T. Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials. Curr Med Res Opin. 2008 May;24(5):1379-84. (Pubitemid 351741570)